Gyre Therapeutics
GYRE
GYRE
46 hedge funds and large institutions have $20.1M invested in Gyre Therapeutics in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
7% less capital invested
Capital invested by funds: $21.6M → $20.1M (-$1.48M)
Holders
46
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.98M | |
| 2 | +$184K | |
| 3 | +$173K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$131K |
| 5 |
BlackRock
New York
|
+$120K |
Top Sellers
| 1 | -$253K | |
| 2 | -$79K | |
| 3 | -$29.8K | |
| 4 |
Charles Schwab
San Francisco,
California
|
-$24.3K |
| 5 |
Barclays
London,
United Kingdom
|
-$16.1K |